[Diseases of the schizophrenia spectrum disorder in old age : Diagnostic and therapeutic challenges]
- PMID: 30109423
- DOI: 10.1007/s00391-018-1436-2
[Diseases of the schizophrenia spectrum disorder in old age : Diagnostic and therapeutic challenges]
Abstract
Background: The number of people with diseases of the schizophrenia spectrum in old age will increase significantly in the coming years. In the literature the topics of schizophrenia and delusional disorders in older and old people are inadequately represented.
Aim: This article gives an overview of the most important diagnostic and differential diagnostic characteristics. Another important aspect is the pharmacological and non-pharmacological treatment options in old age.
Material and methods: The S3 guidelines of the German Association for Psychiatry, Psychotherapy and Psychosomatics (DGPPN) from 2006, the guidelines of the World Federation of Societies of Biological Psychiatry (WFSBP) from 2012, 2013, 2015 and the consensus statement of the Austrian Association for Neuro-Psychopharmacology and Biological Psychiatry (ÖGPB) from 2016 formed the basic literature for this review. In addition, a targeted search in the databases PubMed, PubPsych and Cochrane Library as well as in German Journals, such as DerNervenarzt, Neuropsychiatrie, Psychiatrische Praxis and Zeitschrift für Gerontologie und Geriatrie concerning the keywords schizophrenia, delusional disorder, diagnostics, therapy and older people was carried out.
Results: Besides aspects on epidemiology, clinical manifestation, diagnostics, differential diagnostics and course of the illness, pharmacological and non-pharmacological treatment options are presented.
Conclusion/discussion: In clinical practice a clear diagnostic assignment is often a challenge in older and very old people with psychotic symptoms, The necessary pharmacological treatment is available but is limited by tolerability, comorbidities and polypharmacy. Non-pharmacological treatment options have hardly been investigated.
Keywords: Antipsychotic agents; Classification; Delusional disorder; Elderly patients; Schizophrenia.
Similar articles
-
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.World J Biol Psychiatry. 2006;7(1):5-40. doi: 10.1080/15622970500483177. World J Biol Psychiatry. 2006. PMID: 16509050
-
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.World J Biol Psychiatry. 2005;6(3):132-91. doi: 10.1080/15622970510030090. World J Biol Psychiatry. 2005. PMID: 16173147 Review.
-
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.World J Biol Psychiatry. 2013 Feb;14(1):2-44. doi: 10.3109/15622975.2012.739708. Epub 2012 Dec 6. World J Biol Psychiatry. 2013. PMID: 23216388
-
[Clinical diagnosis and drug therapy of elderly patients with schizophrenia : A restrospective analysis of data in a department of old age psychiatry].Neuropsychiatr. 2016 Jun;30(2):74-81. doi: 10.1007/s40211-016-0183-0. Epub 2016 Jun 13. Neuropsychiatr. 2016. PMID: 27294270 German.
-
[Revised S3 guidelines on schizophrenia : Developmental process and selected recommendations].Nervenarzt. 2020 Jan;91(1):26-33. doi: 10.1007/s00115-019-00813-y. Nervenarzt. 2020. PMID: 31605161 Review. German.
Cited by
-
Medication Dosage Impact on Mortality in Old-Age Individuals with Schizophrenia: A National Cohort Study.Pharmaceuticals (Basel). 2024 Jan 8;17(1):78. doi: 10.3390/ph17010078. Pharmaceuticals (Basel). 2024. PMID: 38256911 Free PMC article.
-
Delusional Disorder in Old Age: A Hypothesis-Driven Review of Recent Work Focusing on Epidemiology, Clinical Aspects, and Outcomes.Int J Environ Res Public Health. 2022 Jun 28;19(13):7911. doi: 10.3390/ijerph19137911. Int J Environ Res Public Health. 2022. PMID: 35805570 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical